Matrixyl 3000 injection is a next-generation anti-aging injectable formula engineered to work in perfect harmony with your skin's innate biological rhythms. Unlike conventional topical treatments that only act on the outermost epidermal layers, this advanced formulation operates by precisely mimicking the skin's natural endogenous distress signals - the very same gentle biological cues that your body naturally releases to initiate targeted collagen repair after minor, controlled skin renewal processes.
Kpeptide GMP factory has been constructed and is operated in strict compliance with the GMP standards outlined in the ICH Q7 guidelines Matrixyl 3000 Injection. Additionally, an independent quality control unit has been established. The factory's quality inspection center is sizable, spanning an area of 1,500 square meters, and is partitioned into a quality and chemical analysis laboratory, an instrument analysis laboratory, and a microbiological testing laboratory.
Our products
Matrixyl 3000 Injection COA
 |
||
| Certificate of Analysis | ||
| Compound name | Matrixyl 3000 injection | |
| Grade | Pharmaceutical grade | |
| CAS No. |
|
|
| Quantity | 10g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202601090051 | |
| MFG | Jan 9th 2026 | |
| EXP | Jan 8th 2029 | |
| Structure |
|
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.55% |
| Loss on drying | ≤1.0% | 0.47% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.87% |
| Single impurity | <0.8% | 0.67% |
| Total microbial count | ≤750cfu/g | 80 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 463ppm |
| Storage |
Store in a sealed, dark, and dry place below 2-8°C |
|
|
|
||
|
|
||
| Chemical Formula: | C39H75N7O10 | |
| Exact Mass: | 802 | |
| Molecular Weight: | 802 | |
| m/z: | 802 (100.0%), 803 (42.2%), 804 (8.7%), 803 (2.6%), 804 (2.1%), 804 (1.1%) | |
| Elemental Analysis: | C, 58.40; H, 9.43; N, 12.22; O, 19.95 | |
Specific Applications Leveraging the Amphiphilic Properties of the Two Palmitoylated Peptides in Matrixyl 3000
Matrixyl 3000 injection consists of two well-characterized palmitoylated peptides - Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. Each peptide is formed by covalently conjugating a short bioactive amino acid sequence with a palmitic acid chain, creating a distinct amphiphilic molecular structure that combines water-soluble peptide segments and lipid-soluble fatty acid moieties. This unique property enables a series of targeted applications in formulation development, delivery system research and skin bioactivity optimization.
Stability Enhancement in Cosmetic Emulsions and Formulations
The amphiphilic nature of the two palmitoylated peptides allows them to behave like mild emulsifier-like active ingredients, helping reduce interfacial tension between the oil and water phases in skincare formulations. This characteristic significantly improves the physical stability of peptide-loaded emulsions, lotions and serums, preventing phase separation and peptide aggregation during long-term storage. Unlike unmodified hydrophilic peptides that often precipitate or degrade in complex cosmetic matrices, these two palmitoylated peptides can be uniformly dispersed in both water-rich and lipid-rich formulation systems without additional solubilizers.
Optimization of Lipid-Based Transdermal Delivery Systems
Their balanced amphiphilic profile makes them ideal model actives for developing and validating liposomes, niosomes and nanostructured lipid carriers. Researchers use these two palmitoylated peptides under the Kpeptide technical framework to test encapsulation efficiency, lipid bilayer compatibility and in vitro skin penetration performance. The lipid-soluble palmitoyl group can insert into the stratum corneum's lipid bilayer, while the hydrophilic peptide segment retains its biological signaling activity, helping overcome the traditional barrier that prevents large hydrophilic peptides from penetrating into the dermis.
Amphiphilic Peptide Self-Assembly and Biomaterial Research
The two palmitoylated peptides in Matrixyl 3000 can act as building blocks for studying peptide self-assembly behavior. Their amphiphilic structure supports the formation of nanofibers, hydrogels and other supramolecular structures, which can be used to develop sustained-release dermal filler precursors and wound-healing biomaterials. These self-assembled systems can slowly release the two signaling peptides in situ,
extending the duration of collagen-stimulating effects in the dermal layer.
Synergistic Penetration-Promoting Effect in Combined Delivery
The two palmitoylated peptides in Matrixyl 3000 have slightly different amphiphilic balance values, which allows them to distribute differently across lipid and aqueous microenvironments in the skin. This difference helps form a complementary penetration-promoting effect: Palmitoyl Tripeptide-1 tends to embed deeper into lipid domains to reach fibroblasts, while Palmitoyl Tetrapeptide-7 distributes more evenly in the dermal aqueous phase to regulate inflammatory factor secretion. This amphiphilic matching design ensures both peptides can reach their respective action sites efficiently, achieving better anti-wrinkle and anti-inflammatory synergies than a single palmitoylated peptide.
Performance Benchmarking for New Palmitoylated Peptide Development
As a clinically validated amphiphilic peptide complex, Matrixyl 3000 is widely used as a reference standard in R&D for new palmitoylated peptide ingredients. Researchers compare the amphiphilic parameters, formulation compatibility and skin retention of newly designed lipid-modified peptides against Matrixyl 3000,
to quickly screen out candidate molecules with better delivery performance and lower irritation.
Applications in Optimizing Lipid-Based Transdermal Delivery Systems
Leveraging the inherent amphiphilic properties of the two palmitoylated peptides in Matrixyl 3000 injection, this Kpeptide-backed product serves as a validated model active for targeted optimization of lipid transdermal delivery systems, with core uses covering three key dimensions. First, it supports the optimization of liposome formulation parameters. The dual-peptide complex can be used to screen lipid bilayer composition, cholesterol ratio and preparation process conditions, helping maximize encapsulation efficiency while ensuring both Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 are uniformly embedded in the lipid phase without component segregation. This avoids the common problem of inconsistent release rates of multi-peptide actives in traditional lipid carriers. Second, it enables targeted penetration performance optimization. The palmitoyl moiety of the two peptides can interact with the intercellular lipid arrangement of the stratum corneum, acting as a self-guided tracer to verify how lipid carriers adjust stratum corneum fluidity. This helps researchers fine-tune particle size and surface modification of lipid systems to achieve deeper dermal delivery,
rather than superficial retention on the skin surface. Third, it serves as a functional evaluation benchmark for lipid delivery systems. With Matrixyl 3000's clinically proven collagen-stimulating and anti-inflammatory endpoints, researchers can directly compare the bioavailability improvement of optimized lipid carriers against free peptide solutions. This provides a quantifiable, activity-based optimization standard, rather than relying only on physical penetration data, to develop lipid delivery systems that retain full peptide bioactivity after skin penetration.
our GMP-certified factory
Our testing center is equipped with a large number of high-value analytical instruments, including nuclear magnetic resonance (NMR) spectrometers, X-ray diffraction (XRD) equipment, liquid crystal chromatography (LCD) systems, magnetic phase chromatography equipment, a Malvern Mastersizer 2000 particle size analyzer, scanning electron microscopes (SEM), high-performance liquid chromatography (HPLC) systems, and gas chromatography (GC) equipment.
A comprehensive standard operating procedure (SOP) documentation system has been established at the factory site to ensure strict adherence to quality management standards such as change control, deviation management, verification, calibration, self-inspection, and quality auditing. From the initial process design stage to material procurement, manufacturing, product testing and release, and after-sales service, our GMP-certified factory consistently implements a holistic process control philosophy to fully guarantee product stability and superior quality.
Procurement Process
Submit procurement requirements, confirm procurement volume, delivery region, and required compliance documents.
Obtain the corresponding batch's COA, MSDS, and other qualification documents, and complete sample verification.
Prepare a complete set of cross-border customs clearance documents for cosmetic raw materials and arrange temperature-controlled cold chain transportation.
Assist in completing customs clearance at the destination. After receipt, in-factory re-inspection can be carried out. Once the products are confirmed to meet standards, the order is closed.
Reference
1.Matrixyl 3000: The Collagen-Boosting Peptide That Transforms Aging Skin.
2.GHK-Cu Peptides Before and After: Dosage, Benefits & How It Works for Skin and Hair.
Frequently Asked Questions
Q: Can this amphiphilic peptide complex be directly used for liposome delivery system encapsulation experiments without extra modification?
-
A: Yes. The two palmitoylated peptides have natural lipid affinity, which can be directly embedded into the phospholipid bilayer of liposomes without additional chemical coupling steps, simplifying the formulation optimization process.
Q: What is the recommended storage condition for research-grade Matrixyl 3000 powder to retain full peptide activity?
-
A: It should be stored sealed at -20°C, protected from light and repeated freeze-thaw cycles. Under this condition, the peptide activity can remain stable for more than 24 months.
Q: Can Matrixyl 3000 be used as a positive control for anti-aging peptide efficacy validation experiments?
-
A: Absolutely. It is a widely recognized positive reference in skin extracellular matrix remodeling studies, with a large number of published clinical and in vitro data that can be directly cited as a performance benchmark.
Q: What is the scientific design logic behind the peptide ratio of Matrixyl 3000 powder?
-
A: It is a synergistic blend of Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. By mimicking the natural repair signals released after collagen degradation in the skin, it directly transmits synthesis instructions to dermal fibroblasts, achieving anti-aging effects rather than through irritating interventions. This mechanism was validated in a 2024 study published.
Q: Are there quantifiable scientific research results regarding the anti-aging efficacy of Matrixyl 3000 powder?
-
A: Relevant controlled trials showed that after 8 weeks of continuous use of the formula containing this ingredient, subjects experienced measurable improvements in the depth of fine lines and wrinkles around the eyes. In a 16-week controlled trial, the 2% concentration of Matrixyl 3000 also demonstrated stable elasticity improvement without significant irritation.
Hot Tags: matrixyl 3000 injection, China matrixyl 3000 injection manufacturers, suppliers, delta conotoxin, Ghk cu Peptide Capsule, Glutathione Liposomal Capsules, Liposomal Glutathione Spray, Nad Capsule, Nad Tablet
